Zhongsheng Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhongsheng Xu has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Yun Liu
Department of Radiology Second Affiliated Hospital of Chongqing Medical University Chongqing P. R. China
6 shared publications Pengchen Ren
Department of Radiology The Second Affiliated Hospital of Chongqing Medical University Chongqing China
2 shared publicationsRanran Luo
Department of Radiology The Second Affiliated Hospital of Chongqing Medical University Chongqing China
2 shared publicationsZening Zhang
Department of Radiology The Second Affiliated Hospital of Chongqing Medical University Chongqing China
2 shared publicationsChenxi Zhang
Department of Radiology The Second Affiliated Hospital of Chongqing Medical University Chongqing China
1 shared publication- Chenxi Zhang
Department of Radiology, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China
1 shared publication
Latest Publications
- Open Access
- 15 February 2026
- Published by Wiley in Advanced Science
- Vol. 13 (23) , e21861
Neutrophil‐Mimetic Nanoscavengers Target the Inflammatory Microenvironment to Eliminate NETs/ROS and Immunomodulate cGAS‐STING Signaling in Septic AKI
Sepsis‐associated acute kidney injury (SAKI) remains a life‐threatening condition with limited therapeutic options, primarily driven by rampant oxidative stress, inflammatory dysregulation. Importantly, aberrant formation of neutrophil extracellular traps (NETs) and sustained innate immune activation further exacerbate renal injury, highlighting the need for strategies that precisely modulate these intertwined pathological mechanisms. Here, we present neutrophil‐mimetic nanoscavengers (MD@NM) that comprise a catalytic core of DNase‐1‐loaded Mn 3 O 4 nanozymes enveloped by a neutrophil membrane engineered to actively target and simultaneously disrupt multiple pathological circuits in SAKI. The neutrophil membrane confers chemokine‐receptor (e.g., CXCR2) mediated homing to injured kidneys, while the Mn 3 O 4 nanozymes catalytically scavenge ROS and the loaded DNase‐1 enzymatically degrades NETs‐derived extracellular DNA, thereby suppressing the cGAS‐STING pathway and skewing macrophage polarization toward an M2 reparative phenotype. In a murine model of LPS‐induced SAKI, MD@NM treatment facilitated robust renal targeting, attenuated neutrophilic infiltration, resolved cytokine storm, and ameliorated structural kidney damage. Collectively, this biomimetic platform represents a novel strategy for precision immunomodulation and multi‐mechanistic therapy against SAKI by integrating antioxidative, NETs‐scavenging, and anti‐inflammatory functions into a single nanotherapeutic agent.
- 15 February 2026
- Published by Wiley in Advanced Science
- Vol. 13 (23) , e21861
Open AccessNeutrophil‐Mimetic Nanoscavengers Target the Inflammatory Microenvironment to Eliminate NETs/ROS and Immunomodulate cGAS‐STING Signaling in Septic AKI
Sepsis‐associated acute kidney injury (SAKI) remains a life‐threatening condition with limited therapeutic options, primarily driven by rampant oxidative stress, inflammatory dysregulation. Importantly, aberrant formation of neutrophil extracellular traps (NETs) and sustained innate immune activation further exacerbate renal injury, highlighting the need for strategies that precisely modulate these intertwined pathological mechanisms. Here, we present neutrophil‐mimetic nanoscavengers (MD@NM) that comprise a catalytic core of DNase‐1‐loaded Mn 3 O 4 nanozymes enveloped by a neutrophil membrane engineered to actively target and simultaneously disrupt multiple pathological circuits in SAKI. The neutrophil membrane confers chemokine‐receptor (e.g., CXCR2) mediated homing to injured kidneys, while the Mn 3 O 4 nanozymes catalytically scavenge ROS and the loaded DNase‐1 enzymatically degrades NETs‐derived extracellular DNA, thereby suppressing the cGAS‐STING pathway and skewing macrophage polarization toward an M2 reparative phenotype. In a murine model of LPS‐induced SAKI, MD@NM treatment facilitated robust renal targeting, attenuated neutrophilic infiltration, resolved cytokine storm, and ameliorated structural kidney damage. Collectively, this biomimetic platform represents a novel strategy for precision immunomodulation and multi‐mechanistic therapy against SAKI by integrating antioxidative, NETs‐scavenging, and anti‐inflammatory functions into a single nanotherapeutic agent.
- 24 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (6) , 2985-3002
NIR-II upconversion nanomaterials for biomedical applications
This review provides a comprehensive overview of recent biomedical applications of upconversion nanomaterials specifically within the near-infrared two-region (NIR-II) window (1000–1700 nm).
- 24 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (6) , 2985-3002
NIR-II upconversion nanomaterials for biomedical applications
This review provides a comprehensive overview of recent biomedical applications of upconversion nanomaterials specifically within the near-infrared two-region (NIR-II) window (1000–1700 nm).
- Open Access
Ultrasound-Assisted Acellular Spinal Cord Scaffold for Spinal Cord Injury Treatment
Spinal cord injury (SCI) treatment remains challenging globally, with limited breakthroughs. Tissue engineering offers promise, particularly using acellular spinal cord scaffolds. This study developed a 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)-crosslinked vascular endothelial growth factor (VEGF)-modified acellular spinal cord scaffold for sustained VEGF release. The results show sustained VEGF release over 20 days without altering the scaffold’s properties. Enhanced stability and mechanical properties were observed without increased cytotoxicity. In a rat SCI model, the system improved motor function, reduced glial scarring, and restored spinal cord morphology and histology, indicating potential for SCI therapy.
Open AccessUltrasound-Assisted Acellular Spinal Cord Scaffold for Spinal Cord Injury Treatment
Spinal cord injury (SCI) treatment remains challenging globally, with limited breakthroughs. Tissue engineering offers promise, particularly using acellular spinal cord scaffolds. This study developed a 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC)-crosslinked vascular endothelial growth factor (VEGF)-modified acellular spinal cord scaffold for sustained VEGF release. The results show sustained VEGF release over 20 days without altering the scaffold’s properties. Enhanced stability and mechanical properties were observed without increased cytotoxicity. In a rat SCI model, the system improved motor function, reduced glial scarring, and restored spinal cord morphology and histology, indicating potential for SCI therapy.
- 7 September 2019
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 46 (1) , 459-474
MCM-41-supported Fe(Mn)/Cu bimetallic heterogeneous catalysis for enhanced and recyclable photo-Fenton degradation of methylene blue
- 7 September 2019
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 46 (1) , 459-474
MCM-41-supported Fe(Mn)/Cu bimetallic heterogeneous catalysis for enhanced and recyclable photo-Fenton degradation of methylene blue
- 12 February 2015
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 17 (12) , 7848-7856
Design and photovoltaic characterization of dialkylthio benzo[1,2-b:4,5-b′]dithiophene polymers with different accepting units
Three dialkylthio benzo[1,2-b:4,5-b′]dithiophene polymers were developed with tuned bandgaps exhibiting a highest PCE value of 5.63% obtained for the polymer solar cells.
- 12 February 2015
- Published by Royal Society of Chemistry (RSC) in Physical Chemistry Chemical Physics
- Vol. 17 (12) , 7848-7856
Design and photovoltaic characterization of dialkylthio benzo[1,2-b:4,5-b′]dithiophene polymers with different accepting units
Three dialkylthio benzo[1,2-b:4,5-b′]dithiophene polymers were developed with tuned bandgaps exhibiting a highest PCE value of 5.63% obtained for the polymer solar cells.